Cellectar Awarded European Patent
Cellectar Biosciences announced today that it has received a European patent for the composition of matter and use protection for the treatment and/or diagnosis of cancer and cancer stem cells for…
Category Archives: Biotech
NRC to Decide on SHINE Operating License by 2021
The U.S. Nuclear Regulatory Commission (NRC) expects to make a final determination regarding the issuance of an operating license to SHINE Medical Technologies by October 2021, the company announced today….
Nimble, Roche Work on SARS-CoV-2 Diagnostics
Nimble Therapeutics will collaborate with Roche Diagnostics to accelerate the discovery of novel peptide-based molecules for the development of SARS-CoV-2 in vitro diagnostic assays, the company announced today. SARS-CoV-2 is…
Nimble Therapeutics, Svar Life Science Collaborate
Nimble Therapeutics and Swedish company Svar Life Science are collaborating to discover, develop and commercialize diagnostic tests based on Nimble’s novel biomarker discovery engine, the company announced today. “We are…
FluGen Helps Create COVID-19 Vaccine
FluGen, along with Bharat Biotech and virologists at the University of Wisconsin, has begun the development and testing of a unique vaccine against COVID-19 called CoroFlu, the company announced recently….
Exact Sciences to Help With COVID-19 Lab Testing
Exact Sciences is one of four organizations to participate in Gov. Tony Evers’ new public-private partnership to increase Wisconsin’s laboratory testing capacity for COVID-19, the governor announced recently. According to…
BioForward Provides Protective Equipment to Local Orgs
BioForward will provide personal protection equipment to Madison-area organizations that serve people with developmental disabilities and seniors, the organization announced recently. “The vulnerable people these organizations assist are at risk…
BrightStar Invests in Stem Pharm
BrightStar Wisconsin Foundation announced recently that it has invested in Stem Pharm, Inc. Financial terms were not disclosed. As previously reported, the biotech company focuses on creating adult stem cell-derived neural…
Exact Sciences Acquires Two Companies
Exact Sciences has acquired Paradigm Diagnostics and Viomics to extend its lab testing and research and development capabilities, the company announced recently. According to a release, Paradigm offers a comprehensive…
Stemina Test Predicts Developmental Toxicity
Stemina Biomarker Discovery announced today that its decTOX quickPredict (devTOXqP) screening platform was able to predict with high accuracy developmental toxicity in humans. The study, which published in the Toxicological Sciences, resulted from…
